Evidence map›Paper›PMID 25475245›Full record

Trial reportBMJ open2014

Congestive heart failure adherence redesign trial: a pilot study.

Ashvarya Mangla, Rami Doukky, Lynda H Powell, Elizabeth Avery, DeJuran Richardson, James E Calvin

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ashvarya ManglaDepartment of Preventive Medicine, Rush University Medical Center, Chicago, Illinois, USA Department of Internal Medicine, OSF St. Francis Medical Center, Peoria, Illinois, USA.
Rami DoukkyDepartment of Preventive Medicine, Rush University Medical Center, Chicago, Illinois, USA Division of Cardiology, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, USA Division of Cardiology, Rush University Medical Center, Chicago, Illinois, USA.
Lynda H PowellDepartment of Preventive Medicine, Rush University Medical Center, Chicago, Illinois, USA.
Elizabeth AveryDepartment of Preventive Medicine, Rush University Medical Center, Chicago, Illinois, USA.
DeJuran RichardsonDepartment of Preventive Medicine, Rush University Medical Center, Chicago, Illinois, USA Department of Mathematics, Lake Forest College, Lake Forest, Illinois, USA.
James E CalvinDepartment of Medicine, University of Western Ontario, London, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveHeart failure (HF) continues to be a leading cause of hospital admissions, particularly in underserved patients. We hypothesised that providing individualised self-management support to patients and feedback on use of evidence-based HF therapies (EBT) to physicians could lead to improvements in care and decrease hospitalisations. To assess the feasibility of conducting a larger trial testing the efficacy of this dual-level intervention, we conducted the Congestive Heart failure Adherence Redesign Trial Pilot (CHART-P), a proof-of-concept, quasi-experimental, feasibility pilot study.

settingA large tertiary care medical centre in Chicago.

participantsLow-income patients (<US$30,000/year) hospitalised for exacerbation of systolic HF (ejection fraction ≤50%) and their physicians. Twenty physicians and 33 patients were enrolled, of whom 23 patients completed the study.

interventionsPhysicians received HF guidelines and periodic individualised feedback on their adherence to EBT. Patients received HF education, support and self-management training for diet and medication adherence by a trained nurse through 11 interactive sessions over a 4-month period. Evaluations were conducted pre-enrolment and 1 month postintervention completion. OUTCOME MEASURES: Feasibility was assessed by the ability to deliver intervention to patients and physicians. Exploratory outcomes included changes in medication and sodium intake for patients and adherence to EBT for physicians.

resultsEighty-seven per cent and 82% of patients received >80% of interventions at 1 month and by study completion, respectively. Median sodium intake declined (3.5 vs 2.0 g; p<0.01). There was no statistically significant change in medication adherence based on electronic pill cap monitoring or the Morisky Medication Adherence Scale (MMAS); however, there was a trend towards improved adherence based on MMAS. All physicians received timely intervention.

conclusionsThis pilot study demonstrated that the protocol was feasible. It provided important insights about the need for intervention and the difficulties in treating patients with a variety of psychosocial problems that undercut their effective care.

Indexed as

Guideline AdherencePatient ComplianceFeasibility StudiesFemaleFollow-Up StudiesHeart FailureHumansMaleMiddle AgedPilot ProjectsRetrospective StudiesStroke VolumeTreatment OutcomeQUALITATIVE RESEARCH

Identifiers

PMID25475245
PMCPMC4256535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.